Financial Ratios

SIRIS LTD.

NSE : NABSE : 524746ISIN CODE : INE282B01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2012Mar2011Mar2010Mar2009Mar2008
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.15-1.33-5.80-3.13-6.60
   CEPS(Rs)-1.11-0.23-4.53-1.86-4.77
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)5.596.738.0713.8716.99
   Tax Rate(%)0.000.00-0.12-0.34-3.29
Margin Ratios
   Core EBITDA Margin(%)
   EBIT Margin(%)
   Pre Tax Margin(%)
   PAT Margin (%)
   Cash Profit Margin (%)
Performance Ratios
   ROA(%)-14.26-14.16-44.28-17.15-26.84
   ROE(%)-18.60-17.98-52.91-20.26-39.91
   ROCE(%)-17.66-17.00-50.72-18.72-29.39
   Asset Turnover(x)0.000.000.000.000.00
   Sales/Fixed Asset(x)0.000.000.000.000.00
   Working Capital/Sales(x)0.000.000.000.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)
   Receivable days
   Inventory Days
   Payable days
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)
   EV/Core EBITDA(x)-9.21-44.47-2.30-5.69-2.62
   EV/EBIT(x)-8.93-7.82-1.79-3.36-1.86
   EV/CE(x)1.371.211.020.650.58
   M Cap / Sales
Growth Ratio
   Net Sales Growth(%)
   Core EBITDA Growth(%)-374.5594.83-146.1959.07-531.83
   EBIT Growth(%)13.9077.04-86.4550.82-105.27
   PAT Growth(%)13.8677.07-85.5652.62-105.52
   EPS Growth(%)13.8677.07-85.5652.62-101.38
Financial Stability Ratios
   Total Debt/Equity(x)0.040.060.050.040.11
   Current Ratio(x)3.523.293.283.604.95
   Quick Ratio(x)3.522.252.352.634.95
   Interest Cover(x)-1736.710.000.00-381.41-89.60
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.